---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-073983"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2026-07-01T11:16:22+00:00"
generated_at: "2026-07-01T11:20:06.803746+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INmune Bio enters warrant inducement; reduces exercise price to $1.40, extends maturity to Dec 2027

## Summary
- Holders exercise 647,112 warrants at reduced price of $1.40/share (from $1.95), generating $905,957 in cash.
- Remaining 50% of April 2024 warrants have maturity extended from June 30, 2026 to December 31, 2027.
- Warrant exercise and amendment executed via Inducement Letter and Second Amendment on June 30, 2026.
- Shares underlying warrants are registered under effective registration statement (File No. 333-279036).

## SEC filing metadata
- accession: 0001213900-26-073983
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2026-07-01T11:16:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/0001213900-26-073983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/ea0296624-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-073983
- JSON: https://secwatch.observer/filing/0001213900-26-073983.json
- Plain text: https://secwatch.observer/filing/0001213900-26-073983.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.